1
|
Abdelfattah OM, Martinez M, Sayed A, ElRefaei M, Abushouk A, Hassan A, Masri A, Winters SL, Kapadia S, Maron B, Rowin EJ, Maron M. Abstract P556: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis. Circulation 2023. [DOI: 10.1161/circ.147.suppl_1.p556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/18/2023]
Abstract
Introduction:
Since hypertrophic cardiomyopathy(HCM) initial description, sudden cardiac death (SCD) has been the most feared complication of HCM.
Hypothesis:
Temporal, geographical, and age-related trends of SCD rates in HCM have drastically decreased over time.
Methods:
Databases were systematically searched to Nov 2021 for studies reporting on SCD event rates in HCM. Patients with SCD equivalents (appropriate ICD shocks and non-fatal SCD) were excluded. Random-e!ects model was utilized to pool study estimates calculating the overall incidence rates(IR) for each time-era, geographical region, and age-group. We analyzed 2 eras (before vs. after 2000, following implementation of ICD in HCM). Following 2000, 5-year intervals were used to reflect the temporal change in SCD.
Results:
98 studies(N=70,510patients and 431,407patient-years) met inclusion criteria. Overall rate of HCM SCD was 0.43%/year (95% CI: 0.37-0.50%; I2=75%; SCD events:1,938; person-years of follow-up: 408,715), with young patients(<18 years) demonstrating a>2-fold-risk for SCD vs. adults(18- 60years) (IR:1.09%; 95% CI: 0.69-1.73% vs. IR: 0.43%; 95% CI: 0.37-0.50%)(P-value for subgroup di!erences:<0.01). Contemporary SCD rates from 2015-present were 0.32%/year; significantly lower compared to 2000 or earlier (IR: 0.32%; 95% CI:0.20-0.52%, vs. IR: 0.73%; 95% CI:0.53-1.02%,respectively). Reported HCM-SCD rates were lowest in North America (IR: 0.28%;95% CI:0.18-0.43%) and highest in Asia(IR: 0.67%; 95% CI:0.54-0.84%).
Conclusions:
Contemporary HCM-related SCD are low (0.32%/year) representing a 2-fold decrease compared to prior treatment eras, with young HCM patients at the highest risk. SCD risk stratification maturation and primary prevention ICD application are likely responsible for the notable decline in SCD trends. Moreover, worldwide geographical disparities in SCD was evident, underscoring the need to increase access to SCD prevention for all HCM patients.
Collapse
|
2
|
Maron B, Daimee U, Olshansky B, Cannom DS, Heidbuchel H, Salberg L, Ackerman M, Carre F, Estes NM, Law I, Link MS, Saarel E, Wilhelm M, Gan G, Lampert RJ. OUTCOMES OF SPORTS PARTICIPATION FOR PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: DATA FROM THE ICD SPORTS REGISTRY. J Am Coll Cardiol 2020. [DOI: 10.1016/s0735-1097(20)30932-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
3
|
Rowin E, Maron B, Wells SB, Burrows A, Firely C, Patel AR, Maron M. GLOBAL LONGITUDINAL STRAIN PREDICTS PROGRESSIVE HEART FAILURE IN NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2020. [DOI: 10.1016/s0735-1097(20)31542-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
4
|
Romashko M, Maron M, Maron B, Udelson J, Testani JM, Rowin E. PREVALENCE, CLINICAL PROFILE, AND OUTCOME OF CARDIORENAL SYNDROME IN SYMPTOMATIC PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)31369-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Fatima A, Maron M, Maron B, Rowin E. IDENTIFICATION OF CARDIAC AMYLOIDOSIS AMONG A COHORT OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)31616-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
6
|
Adalsteinsdottir B, Ho C, Burke M, Danielsen R, Maron B, Seidman J, Seidman C, Gunnarsson G. DIASTOLIC FUNCTION IN MYOSIN-BINDING PROTEIN C FOUNDER MUTATION CARRIERS WITH AND WITHOUT CLINICAL EVIDENCE OF HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)31538-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
7
|
Abt P, Rowin EJ, Maron B, Kiernan M, Vest A, Constantino F, Maron M, DeNofrio D. Heart Transplantation for Hypertrophic Cardiomyopathy: The Tufts Experience. J Card Fail 2017. [DOI: 10.1016/j.cardfail.2017.07.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
Maron B, Bendezu-Quispe G, Dieckmann H, Espinosa C, Garcia P, Dieckmann R. Impact of an Evidence-Based Pediatric Electronic Knowledge System on
Peruvian Physicians’ Perceptions of Care Quality, Learning, Teaching, and
Self-Efficacy. Ann Glob Health 2017. [DOI: 10.1016/j.aogh.2017.03.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
9
|
Miller C, Maron M, Maron B, Rowin E, Estes N, Link M. ANTIARRHYTHMIC MEDICATIONS FOR ATRIAL FIBRILLATION APPEAR REASONABLY SAFE IN HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2017. [DOI: 10.1016/s0735-1097(17)33757-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
10
|
Harris KM, Creswell L, Thomas T, Haas T, Tung M, Isaacson E, Garberich R, Maron B. FATALITIES IN UNITED STATES TRIATHLONS: AN EXPANDED PROFILE. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)31633-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
11
|
Maurer MS, Ginns J, Maron B, Olivotto I, Lesser J, Gruner C, Crean A, Rakowski H, Rowin E, Lombardi M, Spirito P, Biagini E, Autore C, Manning W, Tomberli B, Maron M, Chan R. THE MYOCARDIAL CONTRACTION FRACTION (MCF) IS ASSOCIATED WITH NYHA CLASS AS WELL AS DELAYED ENHANCEMENT BY CARDIAC MRI IN HYPERTROPHIC CARDIOMYOPATHY AND PREDICTS SUDDEN CARDIAC DEATH. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)31509-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
12
|
Sorajja P, Pedersen W, Bae R, Lesser J, Jay D, Harris K, Maron B. FIRST EXPERIENCE WITH PERCUTANEOUS MITRAL VALVE PLICATION AS PRIMARY THERAPY FOR SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)31517-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
13
|
Lynge TH, Risgaard B, Jabbari R, Glinge C, Bundgaard H, Maron B, Haunsø S, Winkel BG, Tfelt-Hansen J. Cardiac symptoms before sudden cardiac death caused by hypertrophic cardiomyopathy: a nationwide study among the young in Denmark. Europace 2016; 18:1801-1808. [PMID: 26823388 DOI: 10.1093/europace/euv403] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2015] [Accepted: 11/06/2015] [Indexed: 01/14/2023] Open
Abstract
AIMS Hypertrophic cardiomyopathy (HCM) is a frequent cause of sudden cardiac death (SCD) among the young (SCDY). The aim of this study was to characterize symptoms before SCDY due to HCM. METHODS AND RESULTS Through review of all death certificates, we identified all SCDs in Danes aged 1-35 years in 2000-2009. Nationwide we included all deaths (n = 8756) and identified 431 autopsied SCDYs. All available records from hospitals and general practitioners were retrieved. To compare symptoms, we included a control groups consisting of traffic accident victims (n = 74). In the 10-year study period, 431 autopsied SCDY cases were reviewed and 38 cases (9%) were included, of which 22 (58%) had morphologic findings diagnostic of HCM and 16 (42%) had findings suggestive, but not diagnostic, of HCM ('possible HCM'). Cardiac symptoms >1 h prior to death were reported in 21 (55%) of cases, and 16 (42%) sought medical attention. One (1%) control had cardiac symptoms before death. Consequently, a significantly higher proportion of cases had cardiac symptoms before death and cases more often sought medical attention than controls (P < 0.001). CONCLUSION In conclusion, this nationwide study demonstrates a high frequency of cardiac symptoms prior to death in SCDY cases who died of HCM, as 55% had cardiac symptoms and nearly half of the cases sought medical attention.
Collapse
Affiliation(s)
- Thomas Hadberg Lynge
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark .,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Bjarke Risgaard
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Reza Jabbari
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Charlotte Glinge
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Henning Bundgaard
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Department of Medicine and Surgery, University of Copenhagen, Copenhagen, Denmark
| | - Barry Maron
- The Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA
| | - Stig Haunsø
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.,Department of Medicine and Surgery, University of Copenhagen, Copenhagen, Denmark
| | - Bo Gregers Winkel
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
| | - Jacob Tfelt-Hansen
- Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), University of Copenhagen, Copenhagen, Denmark.,Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.,Department of Medicine and Surgery, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
14
|
Kalra A, Harris K, Maron B, Ho C, Garberich R, Haas T, Maron B. DOPPLER TISSUE IMAGING PREDICTS PROGRESSIVE HEART FAILURE PROGNOSIS IN HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2015. [DOI: 10.1016/s0735-1097(15)61215-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
15
|
Adalsteinsdottir B, Teekakirikul P, Maron B, Burke M, Danielsen R, Gardarsdottir M, Palsson R, Desnick R, Seidman C, Seidman JG, Gunnarsson G. UNEXPECTED IDENTIFICATION OF FABRY DISEASE AMONG PATIENTS WITH THE CLINICAL DIAGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY IN ICELAND. J Am Coll Cardiol 2014. [DOI: 10.1016/s0735-1097(14)60822-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
16
|
Caselli S, Maron M, Moral JAU, Pandian N, Maron B, Pelliccia A. LEFT VENTRICULAR HYPERTROPHY IN ATHLETES: THE “GRAY-ZONE” REVISITED. J Am Coll Cardiol 2014. [DOI: 10.1016/s0735-1097(14)60842-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Adalsteinsdottir B, Teekakirikul P, Maron B, Gudbjartsson DF, Holm H, Burke M, Danielsen R, Seidman C, Seidman JG, Gunnarsson G. HYPERTROPHIC CARDIOMYOPATHY IN ICELAND IS CHARACTERIZED BY LOW EVENT RATE CLINICAL COURSE AND MYBPC3 FOUNDER MUTATION. J Am Coll Cardiol 2014. [DOI: 10.1016/s0735-1097(14)60827-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
18
|
Gruner C, Chan R, Appelbaum E, Rowin E, Care M, Williams L, Gibson M, Lesser J, Haas T, Udelson J, Manning W, Tomberli B, Olivotto I, Maron B, Crean A, Maron M, Rakowski H. LACK OF PHENOTYPIC DIFFERENCES BY CMRI IN THE TWO MOST COMMON SARCOMERE PROTEIN GENE MUTATIONS IN HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2013. [DOI: 10.1016/s0735-1097(13)61222-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes M, Link M, Maron B, Marcus F, Scheinman M, Wilkoff B, Zipes D, Berul C, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of Sports for Patients With ICDs: Results of a Prospective Multinational Registry. Heart Rhythm 2012. [DOI: 10.1016/j.hrthm.2012.06.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
20
|
Maron MS, Rowin E, Lin D, Appelbaum E, Gibson CM, Lesser J, Haas T, Lindberg J, Udelson J, Manning W, Maron B. PREVALENCE AND CLINICAL PROFILE OF MYOCARDIAL CRYPTS IN HYPERTROPHIC CARDIOMYOPATHY. J Am Coll Cardiol 2011. [DOI: 10.1016/s0735-1097(11)60191-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
Maron MS, Harrigan C, Olivotto I, Appelbaum E, Gibson CM, Lesser J, Haas T, Udelson J, Manning W, Maron B. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2010. [DOI: 10.1186/1532-429x-12-s1-p187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
22
|
Maron B. Hypertrophic Cardiomyopathy in the âreal Worldâ: Prevalence, Demographics and Clinical Expression in an Unselected and Unreferred Hospital-based Patient Population. J Am Coll Cardiol 1998. [DOI: 10.1016/s0735-1097(97)84496-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
|
24
|
Brosius FC, Schwartz DE, Gleason WL, Maron B, Jones M, Roberts WC. Left atrial-to-right atrial shunt without atrial septal defect or precordial murmur. Pulmonary varix and hypertrophic cardiomyopathy. Chest 1982; 81:91-4. [PMID: 6459214 DOI: 10.1378/chest.81.1.91] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
|